Rockefeller Capital Management’s Merit Medical Systems MMSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.6M | Sell |
196,374
-54,400
| -22% | -$3.59M | 0.02% | 614 |
|
|
2026
Q1 | $17.3M | Sell |
250,774
-184,813
| -42% | -$14.4M | 0.03% | 481 |
|
|
2025
Q4 | $38.4M | Sell |
435,587
-127,051
| -23% | -$10.8M | 0.07% | 271 |
|
|
2025
Q3 | $46.8M | Buy |
562,638
+64,198
| +13% | +$5.59M | 0.09% | 202 |
|
|
2025
Q2 | $46.6M | Sell |
498,440
-4,046
| -0.8% | -$383K | 0.1% | 197 |
|
|
2025
Q1 | $53.1M | Sell |
502,486
-61,413
| -11% | -$6.34M | 0.13% | 159 |
|
|
2024
Q4 | $54.5M | Sell |
563,899
-77,806
| -12% | -$7.75M | 0.14% | 154 |
|
|
2024
Q3 | $63.4M | Buy |
641,705
+3,068
| +0.5% | +$281K | 0.17% | 131 |
|
|
2024
Q2 | $54.9M | Buy |
638,637
+84,061
| +15% | +$6.61M | 0.16% | 138 |
|
|
2024
Q1 | $42M | Buy |
554,576
+2,371
| +0.4% | +$183K | 0.12% | 175 |
|
|
2023
Q4 | $41.9M | Buy |
552,205
+95,320
| +21% | +$6.65M | 0.14% | 159 |
|
|
2023
Q3 | $31.5M | Sell |
456,885
-25,384
| -5% | -$1.83M | 0.12% | 187 |
|
|
2023
Q2 | $40.3M | Sell |
482,269
-89,890
| -16% | -$7.31M | 0.16% | 153 |
|
|
2023
Q1 | $42.3M | Buy |
572,159
+526,385
| +1,150% | +$36.9M | 0.18% | 132 |
|
|
2022
Q4 | $3.23M | Sell |
45,774
-544,657
| -92% | -$36.4M | 0.02% | 614 |
|
|
2022
Q3 | $33.4M | Sell |
590,431
-6,042
| -1% | -$348K | 0.17% | 134 |
|
|
2022
Q2 | $32.4M | Sell |
596,473
-2,324
| -0.4% | -$142K | 0.17% | 133 |
|
|
2022
Q1 | $39.8M | Buy |
598,797
+485
| +0.1% | +$29.2K | 0.19% | 121 |
|
|
2021
Q4 | $37.3M | Sell |
598,312
-4,723
| -0.8% | -$316K | 0.17% | 137 |
|
|
2021
Q3 | $43.3M | Sell |
603,035
-6
| -0% | -$407 | 0.23% | 105 |
|
|
2021
Q2 | $39M | Sell |
603,041
-59,833
| -9% | -$3.7M | 0.22% | 106 |
|
|
2021
Q1 | $39.7M | Sell |
662,874
-10,388
| -2% | -$595K | 0.27% | 88 |
|
|
2020
Q4 | $37.4M | Sell |
673,262
-94,795
| -12% | -$4.89M | 0.28% | 85 |
|
|
2020
Q3 | $33.4M | Sell |
768,057
-2,681
| -0.3% | -$121K | 0.31% | 75 |
|
|
2020
Q2 | $35.2M | Sell |
770,738
-16,274
| -2% | -$657K | 0.37% | 58 |
|
|
2020
Q1 | $24.6M | Sell |
787,012
-12,009
| -2% | -$428K | 0.32% | 67 |
|
|
2019
Q4 | $24.9M | Buy |
799,021
+112,130
| +16% | +$3.21M | 0.31% | 79 |
|
|
2019
Q3 | $20.9M | Buy |
686,891
+128,554
| +23% | +$5.2M | 0.28% | 84 |
|
|
2019
Q2 | $33.3M | Sell |
558,337
-4,244
| -0.8% | -$243K | 0.46% | 51 |
|
|
2019
Q1 | $34.8M | Sell |
562,581
-986
| -0.2% | -$55.9K | 0.5% | 50 |
|
|
2018
Q4 | $31.5M | Sell |
563,567
-157,361
| -22% | -$9.35M | 0.55% | 47 |
|
|
2018
Q3 | $44.3M | Sell |
720,928
-13,574
| -2% | -$780K | 0.67% | 43 |
|
|
2018
Q2 | $37.6M | Sell |
734,502
-44,267
| -6% | -$2.19M | 0.61% | 48 |
|
|
2018
Q1 | $35.3M | Buy |
+778,769
| New | +$35.3M | 0.58% | 51 |
|
Other funds holding MMSI
CCA
NAMI
CAM
Rockefeller Capital Management's MMSI Position: Q2 2026 in Review
Rockefeller Capital Management reduced its Merit Medical Systems (MMSI) stake by 22% in Q2 2026, selling an estimated $3.59M and leaving 196,374 shares worth $13.6M. The position accounts for 0.02% of the portfolio, ranked #614.
Rockefeller Capital Management first reported a position in MMSI in Q1 2018 and has held it in 34 quarters since. The position peaked at $63.4M in Q3 2024. 403 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.
- Rockefeller Capital Management held 196,374 shares of Merit Medical Systems worth $13.6M as of Q2 2026.
- Rockefeller Capital Management sold 54,400 Merit Medical Systems shares in Q2 2026, an estimated $3.59M.
- Merit Medical Systems made up 0.02% of Rockefeller Capital Management's portfolio in Q2 2026, its #614 holding.
- Rockefeller Capital Management first reported a position in Merit Medical Systems in Q1 2018 and has held it in 34 quarters since.
- Rockefeller Capital Management's Merit Medical Systems position peaked at $63.4M in Q3 2024.
- 403 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.